Tarsus Pharmaceuticals (TARS) Capital Expenditures (QoQ) (2020 - 2026)
Tarsus Pharmaceuticals (TARS) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tarsus Pharmaceuticals | 2.52 Bn | 2.41 Bn | 152.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.10% |
| Dec 31, 2025 | 9,186.96% |
| Sep 30, 2025 | -109.19% |
| Jun 30, 2025 | 69.66% |
| Mar 31, 2025 | -60.90% |
| Dec 31, 2024 | 133.23% |
| Sep 30, 2024 | 184.80% |
| Jun 30, 2024 | -538.51% |
| Mar 31, 2024 | 122.19% |
| Dec 31, 2023 | -178.71% |
| Sep 30, 2023 | 500.00% |
| Jun 30, 2023 | -51.18% |
| Mar 31, 2023 | 142.86% |
| Jun 30, 2022 | -153.42% |
| Mar 31, 2022 | 132.39% |
| Dec 31, 2021 | -119.33% |
| Sep 30, 2021 | 341.64% |
| Jun 30, 2021 | -184.78% |
| Mar 31, 2021 | 2,514.58% |
| Dec 31, 2020 | 113.95% |